HomeCAPR • NASDAQ
add
Capricor Therapeutics Inc
Previous close
$6.44
Day range
$6.27 - $6.47
Year range
$4.20 - $23.40
Market cap
290.76M USD
Avg Volume
1.36M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.67M | 85.48% |
Net income | -25.91M | -135.56% |
Net profit margin | — | — |
Earnings per share | -0.57 | -62.86% |
EBITDA | -27.23M | -142.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 122.80M | 316.81% |
Total assets | 133.57M | 248.95% |
Total liabilities | 28.59M | 6.79% |
Total equity | 104.98M | — |
Shares outstanding | 45.72M | — |
Price to book | 2.80 | — |
Return on assets | -48.23% | — |
Return on capital | -59.00% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -25.91M | -135.56% |
Cash from operations | -20.12M | -63.75% |
Cash from investing | 14.55M | -0.99% |
Cash from financing | 19.58K | -99.05% |
Net change in cash | -5.55M | -224.13% |
Free cash flow | -8.44M | 1.61% |
About
CEO
Founded
2005
Website
Employees
160
